148 related articles for article (PubMed ID: 18554598)
1. Relationship between serum progesterone and tumor necrosis factor production in postmenopausal women undergoing estrogen/medroxyprogesterone therapy.
Stopińska-Głuszak U; Jóźwiak J; Radomski D; Głuszak O; Roszkowski PI; Malejczyk J
Fertil Steril; 2009 Apr; 91(4 Suppl):1344-6. PubMed ID: 18554598
[TBL] [Abstract][Full Text] [Related]
2. Effect of estrogen/progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal women.
Stopińska-Głuszak U; Waligóra J; Grzela T; Głuszak M; Jóźwiak J; Radomski D; Roszkowski PI; Malejczyk J
J Reprod Immunol; 2006 Feb; 69(1):65-75. PubMed ID: 16236362
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal changes in serum cytokine levels and hormone replacement therapy.
Kamada M; Irahara M; Maegawa M; Ohmoto Y; Takeji T; Yasui T; Aono T
Am J Obstet Gynecol; 2001 Feb; 184(3):309-14. PubMed ID: 11228479
[TBL] [Abstract][Full Text] [Related]
4. The impact of tibolone and hormone therapy on serum C-reactive protein, tumor necrosis factor-alpha and hepatocyte growth factor in postmenopausal women.
Sezer Ozer K; Erenus M; Yoldemir T
Climacteric; 2009 Feb; 12(1):66-71. PubMed ID: 19012050
[TBL] [Abstract][Full Text] [Related]
5. Relationship between circulating tumor necrosis factor system and bone mass before and after estrogen plus progestogen therapy.
Kim JG; Ku SY; Kim H; Chun SW; Suh CS; Choi YM
Menopause; 2009; 16(3):534-8. PubMed ID: 19225428
[TBL] [Abstract][Full Text] [Related]
6. Oxytocinergic activity is linked to lower blood pressure and vascular resistance during stress in postmenopausal women on estrogen replacement.
Light KC; Grewen KM; Amico JA; Brownley KA; West SG; Hinderliter AL; Girdler SS
Horm Behav; 2005 May; 47(5):540-8. PubMed ID: 15811355
[TBL] [Abstract][Full Text] [Related]
7. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
[TBL] [Abstract][Full Text] [Related]
8. The effect of low dose zinc supplementation to serum estrogen and progesterone levels in post-menopausal women.
Sunar F; Gormus ZI; Baltaci AK; Mogulkoc R
Biol Trace Elem Res; 2008 Dec; 126 Suppl 1():S11-4. PubMed ID: 18759067
[TBL] [Abstract][Full Text] [Related]
9. Effect of oral conjugated equine estrogen combined with medroxyprogesterone acetate on plasma homocysteine levels in postmenopausal women.
Hsu SC; Liu CM; Long CY; Yang CH; Lee JN; Tsai EM
Fertil Steril; 2005 Oct; 84(4):1037-9. PubMed ID: 16213869
[TBL] [Abstract][Full Text] [Related]
10. Effect of hormone replacement therapy on the production of bone-resorbing cytokines by peripheral blood cells in postmenopausal women.
Uemura H; Kamada M; Maegawa M; Ohmoto Y; Murata K; Kuwahara A; Matsuzaki T; Yasui T; Takeji T; Irahara M
Horm Metab Res; 2005 Apr; 37(4):226-30. PubMed ID: 15952082
[TBL] [Abstract][Full Text] [Related]
11. The effect of different preparations of hormone therapy on tumor necrosis factor-alpha levels in women with surgical menopause.
Somunkiran A; Coskun A; Demirci F; Yucel O
Gynecol Endocrinol; 2008 Feb; 24(2):79-83. PubMed ID: 18210330
[TBL] [Abstract][Full Text] [Related]
12. [The regulation of estradiol and progesterone in tumor necrosis factor production in vitro].
Lu S; Shi Y; Yi H
Zhonghua Fu Chan Ke Za Zhi; 1995 May; 30(5):294-7. PubMed ID: 7648911
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis.
Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL
Menopause; 2009; 16(5):978-83. PubMed ID: 19390463
[TBL] [Abstract][Full Text] [Related]
14. Use of combined estrogen-androgen preparations in the postmenopause: evidence from clinical studies.
Sherwin BB
Int J Fertil Womens Med; 1998; 43(2):98-103. PubMed ID: 9609209
[TBL] [Abstract][Full Text] [Related]
15. Short-term estrogen replacement therapy reduces platelet marker levels in Malaysian postmenopausal women.
Sheikh SA; Roshan TM; Khattak MN; Baig AA; Noor SJ; Hassan R; Zaki NM
Menopause Int; 2011 Mar; 17(1):6-10. PubMed ID: 21427417
[TBL] [Abstract][Full Text] [Related]
16. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
17. Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.
Seeger H; Wallwiener D; Mueck AO
Gynecol Endocrinol; 2008 Oct; 24(10):576-9. PubMed ID: 19012101
[TBL] [Abstract][Full Text] [Related]
18. Auditory evoked responses in postmenopausal women on hormone replacement therapy.
Khaliq F; Tandon OP; Goel N
Indian J Physiol Pharmacol; 2003 Oct; 47(4):393-9. PubMed ID: 15266950
[TBL] [Abstract][Full Text] [Related]
19. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
[TBL] [Abstract][Full Text] [Related]
20. Is hormone replacement therapy (estrogen plus progestin) effective for the treatment of urinary incontinence in postmenopausal women?
Easton BT
J Fam Pract; 2001 May; 50(5):470. PubMed ID: 11350716
[No Abstract] [Full Text] [Related]
[Next] [New Search]
